Archive for January, 2012
2012 Cresset European User Group Meeting Information
30 January 2012
Cresset is pleased to host our annual European User Group meeting in Cambridge at the lovely Madingley Hall June 20-21, 2012. This two day event features software training with our exciting new products followed by an interesting scientific program including presentations from partners, customers and researchers. The agenda is currently in development and scientists are encouraged to contact [...]
Cresset ACS Spring 2012- ‘The Chemistry of Life’
30 January 2012
We’re looking forward to another great event at the ACS Spring 2012 National Meeting in San Diego, March 25 – 29, 2012. We encourage delegates to visit us at booth 1837 for a chance to enter the latest Design a Molecule competition and meet the Cresset team. This event will be attended by North American Sales Manager [...]
January 2012 Newsletter
19 January 2012
Welcome to 2012! To start the year off right, we’ve relaunced our services website to feature our new flexible service options, and included more of the good stuff- case studies. Take a look here…. Cresset & Optibrium Collaborate We’re absolutely delighted to announce a new partnership with the good people at Optibrium. The collaboration will [...]
2012 Cresset European User Group Meeting
19 January 2012
Cresset is pleased to host our annual European User Group Meeting in Cambridge, UK at the lovely Madingley Hall. This two day event features software training with our exciting new products followed by an interesting scientific program including presentations from a combination of partners, customers and researchers. The agenda is currently in development and scientists [...]
Meet the CSO: Mark Mackey
19 January 2012
Dr Mark Mackey founded Cresset with Andy Vinter almost 10 years ago and has been involved in every product Cresset has released since. Before Cresset, Mark earned a PhD in Chemistry from Cambridge, and developed his molecular modelling and software development skills at Napp Pharmaceuticals and Merck. Mark is the bright, focussed man behind the [...]
